Blow for UK drugs sector as Merck scraps £1bn expansion
Merck has canceled a £1 billion expansion in the UK, citing insufficient investment in life sciences. This decision poses a setback for the UK drugs sector.
WPN Brief
Merck has canceled a £1 billion expansion in the UK, citing insufficient investment in life sciences. This decision poses a setback for the UK drugs sector.
Ask WPN AI